According to Biolase 's latest financial reports the company's current EPS (TTM) is -$264.93. In 2022 the company made an earnings per share (EPS) of -$410.98 a decrease over its 2021 EPS that were of -$267.48.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$264.93 | -35.54% |
2022 | -$410.98 | 53.65% |
2021 | -$267.48 | -81.87% |
2020 | -$1,475 | -25.32% |
2019 | -$1,975 | -24.76% |
2018 | -$2,625 | -26.06% |
2017 | -$3,550 | 4.33% |
2016 | -$3,403 | -14.71% |
2015 | -$3,989 | -26.09% |
2014 | -$5,398 | 35.41% |
2013 | -$3,986 | 244.31% |
2012 | -$1,158 | -38.05% |
2011 | -$1,869 | -64.8% |
2010 | -$5,309 | 347.66% |
2009 | -$1,186 | -71.05% |
2008 | -$4,097 | 22.58% |
2007 | -$3,342 | 55% |
2006 | -$2,156 | -74.03% |
2005 | -$8,301 | -22.22% |
2004 | -$10,673 | -208.79% |
2003 | $9,811 | 1720% |
2002 | $539.05 | -171.43% |
2001 | -$754.66 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Align Technology
ALGN | $4.07 | -101.54% | ๐บ๐ธ USA |
![]() Dentsply Sirona
XRAY | -$4.76 | -98.20% | ๐บ๐ธ USA |